Cookie Img
Send SMS    Call Me Free
Home » Products » Anti-Cancer Products » Imbruvica

Imbruvica

Imbruvica
Imbruvica
Product Code : 50
Brand Name : Ibrutinib
Product Specifications
  • Application
  • Control Virus
  • Formulations Type
  • Chemical Drug
  • Formulations Form
  • Capsules
  • Gender/Age Group
  • Adult
Trade Information
  • Minimum Order Quantity
  • 1 to 1000000
  • Main Export Market(s)
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • Main Domestic Market
  • All India
Product Description

Imbruvica (ibrutinib) is a cancer medication that interferes with the growth and spread of cancer cells in the body.

Imbruvica is used to treat certain types of non-Hodgkin lymphoma, including mantle cell lymphoma (MCL), Waldenstrom's macroglobulinemia, and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in people with or without 17p deletion.

Imbruvica is sometimes given when other medicines have not been effective.

Imbruvica was approved to treat mantle cell lymphoma by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, tumors responded to this medicine. However, it has not been shown that ibrutinib can improve symptoms or lengthen survival time in people with this type of lymphoma.

Important information

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.


AMBICA PHARMA

Contact Us

( *represents compulsory fields )

Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



AMBICA PHARMA All Rights Reserved.